Lord Abbett Health Care F (LHCFX)

Fund Assets	8.74M
Expense Ratio	0.78%
Min. Investment	$0.00
Turnover	91.00%
Dividend (ttm)	0.06
Dividend Yield	0.24%
Dividend Growth	-36.05%
Payout Frequency	Annual
Ex-Dividend Date	Dec 2, 2025

Previous Close	24.11
YTD Return	5.61%
1-Year Return	15.48%
5-Year Return	24.29%
52-Week Low	20.76
52-Week High	25.41
Beta (5Y)	n/a
Holdings	55
Inception Date	Jul 31, 2019

About LHCFX

Lord Abbett Health Care Fund Class F is a mutual fund that primarily targets long-term capital growth by investing in a diversified portfolio of companies operating within the health care sector. Its investment universe typically includes pharmaceuticals, biotechnology firms, health care equipment and services, and related industries. The fund leverages sector expertise to identify opportunities among both established and innovative health care enterprises, aiming to capture growth trends driven by medical advancements, demographic shifts, and evolving global health needs. Lord Abbett Health Care Fund Class F appeals to investors seeking sector-specific exposure to health care, which is a vital and consistently evolving segment of the global economy. By focusing on this sector, the fund plays a specialized role in the broader market, offering access to companies that may benefit from increased health care spending, technological breakthroughs, and regulatory changes.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: LHCFX
• Share Class: Class F
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCFX had a total return of 15.48% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.82%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCIX	Class I	0.78%
LHCTX	Class R5	0.78%

Top 10 Holdings

44.28% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.72%
UnitedHealth Group Incorporated	UNH	5.57%
Johnson & Johnson	JNJ	5.11%
Novartis AG	NOVN	4.32%
Natera, Inc.	NTRA	3.71%
Gilead Sciences, Inc.	GILD	3.64%
CVS Health Corporation	CVS	3.44%
Guardant Health, Inc.	GH	2.69%
Galderma Group AG	GALD	2.68%
Thermo Fisher Scientific Inc.	TMO	2.39%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.0564	Dec 2, 2025
Nov 26, 2024	$0.0882	Nov 26, 2024
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3119	Nov 24, 2020
Nov 21, 2019	$0.0011	Nov 21, 2019

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 17, 2026

Data Sources Report a data error